Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to NUPL2 (AC005082.2)
- Target
- AC005082.2
- Molecular classification
- Natural antisense transcript, Long noncoding RNA, Noncoding RNA
01
Overview
AC005082.2 is a natural antisense transcript overlapping the NUPL2 gene on the human genome. Natural antisense transcripts (NATs) are noncoding RNAs transcribed in the opposite direction to a sense gene. They often function in regulation of gene expression of their sense partner via mechanisms such as transcriptional interference, RNA duplex formation, chromatin remodeling, or RNA masking. While a significant proportion of human genes have NATs, only a subset have well-characterized functions. For AC005082.2, there is currently no evidence of protein-coding potential, defined biological function, disease association, or therapeutic targeting. It is best classified as a noncoding RNA transcript (antisense) with unknown specific significance.
- Other names
- AC005082.2Novel transcript, antisense to NUPL2
02
Biological functions
Gene expression regulation (general NAT function)Regulatory RNA
Beyond the preview
Go deeper on Novel transcript, antisense to NUPL2 (AC005082.2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to NUPL2 (AC005082.2).